Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients
Michael J. Mauro
Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel
The future of CML treatment and cures
Role of nurses in fungal disease management
Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?